A new study finds there is a significantly increased risk of heart problems with drugs like DiaBeta and Micronase, compared to metformin, when patients have kidney function problems.
A new study warns that rates of pregnancy complications are higher with DiaBeta, Micronase and similar drugs than with insulin when used to treat pregnant women with gestational diabetes.
Combining Januvia and Onglyza with certain other diabetes drugs could result in dangerously low blood glucose levels, according to the findings of a new study.
The findings of a new study suggest that DiaBeta, Micronase, Glynase and other glyburide-based gestational diabetes drugs may increase the risk of newborns suffering birth injury and complications.
A new study warns that some diabetes drugs may cross the placenta, potentially affecting unborn children.
